MicroStockHub
- After shares declined almost 49% in Monday’s trading session, Cumberland Pharmaceuticals (CPIX) said it will file an NDA for cardiomyopathy associated with Duchenne muscular dystrophy candidate ifetroban.
- The company held a pre-NDA meeting with the US FDA recently and intends to
